Skip to main content

Table 3 Subgroup analysis of overall survival and progression free survival

From: Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis

Subgroup

No. of studies

Participants

HR (95% CI)

P

Study heterogeneity

Analysis model

RHR

RFA

Total

Χ2

I2 (%)

P

OS

 Patients in China

7

559

695

1254

0.79 (0.65–0.95)

0.013

6.11

1.9

0.410

Fixed

 Tumor size≦3 cm

3

207

243

450

1.03 (0.69–1.52)

0.897

0.45

0

0.799

Fixed

 Tumor size>3 cm

2

164

188

352

0.57 (0.37–0.89)

0.014

0.02

0

0.900

Fixed

PFS

 Patients in China

4

249

273

522

0.79 (0.64–0.98)

0.029

0.24

0

0.971

Fixed

 Tumor size≦3 cm

2

177

171

348

0.99 (0.71–1.37)

0.929

0.34

0

0.563

Fixed

  1. No. number, OS overall survival, PFS progression-free survival